Peptilogics
PrivateLast Round
Series B
Extension
Oct 16, 2025
Est. Valuation
$420M
Total Funding Raised
$135.67M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Peptilogics is a biotechnology company that develops novel peptide therapeutics using an AI-powered drug discovery platform to treat multidrug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptilogics Comparables
Compare Peptilogics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Osteal Therapeutics | 83% | |
| Trellis Bioscience | 82% | |
| Omnix Medical Ltd. | 78% |
Peptilogics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Oct 16, 2025 | ||||
| Grant | Jan 9, 2025 | ||||
| Series B | Dec 21, 2020 | ||||
| Grant | Feb 25, 2020 | ||||
| Series A | Sep 29, 2017 | ||||
Seed | Oct 21, 2016 |
Key People
Founding team and executive leadership
Peptilogics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pittsburgh Life Sciences Greenhouse | Seed |
| Narya Capital | Series B Extension |
| AMR Action Fund | Series B Extension |
| BlueTree Allied Angels | Series A |
| CARB-X | Grant |
| Beyond Ventures | Series B Extension |
| Founders Fund | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 69% MoM.
- Oct 16, 2025
$78M round led by Founders Fund and Presight Capital.
Recent news
Latest coverage and updates
- is_developingAug 18, 2026
Peptilogics is developing zaloganan.
- hiresAug 18, 2026
Peptilogics hired Tim Czartoski as board of directors on Aug 18th '26.
Peptilogics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Peptilogics's valuation, stock price, and market status.
Is Peptilogics a public or private company?
Peptilogics is a private company.
What is the current stock price of Peptilogics?
Peptilogics is a private company with no public stock price. No recent secondary market data is available.
How much is Peptilogics worth (valuation)?
Peptilogics's valuation is estimated at $420.0M based on funding round data.
Can I buy Peptilogics stock?
Peptilogics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Peptilogics's last funding round?
Peptilogics's most recent funding round was Series B Extension on October 16, 2025.
Who are the main investors in Peptilogics?
Key investors in Peptilogics include Founders Fund, Thiel Bio, Presight Capital.
Will Peptilogics IPO soon?
No public IPO plans have been announced for Peptilogics.
How can I track Peptilogics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Peptilogics's secondary market activity and sign up for updates.